BAKER CHARLES A
Insider CIK 1225470 · PGNX Director · REGN Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| REGN REGENERON PHARMACEUTICALS | A Award deriv | 2018-01-02 | 2018-01-03 | 7,439 | — | $0 | 7,439 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | M Exercise deriv | 2017-09-29 | 2017-10-03 | 2,000 | — | $0 | 0 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | S Sale | 2017-09-29 | 2017-10-03 | 2,000 | $450.00 | $900.0K | 9,000 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | M Exercise | 2017-09-29 | 2017-10-03 | 2,000 | $18.61 | $37.2K | 11,000 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | A Award deriv | 2017-01-03 | 2017-01-05 | 7,830 | — | $0 | 7,830 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | M Exercise deriv | 2016-12-12 | 2016-12-14 | 3,000 | — | $0 | 2,000 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | S Sale | 2016-12-12 | 2016-12-14 | 1,200 | $391.36 | $469.6K | 10,200 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | M Exercise | 2016-12-12 | 2016-12-14 | 3,000 | $18.61 | $55.8K | 12,000 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | S Sale | 2016-12-12 | 2016-12-14 | 600 | $393.64 | $236.2K | 9,200 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | S Sale | 2016-12-12 | 2016-12-14 | 400 | $392.41 | $157.0K | 9,800 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | S Sale | 2016-12-12 | 2016-12-14 | 200 | $394.33 | $78.9K | 9,000 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | S Sale | 2016-12-12 | 2016-12-14 | 600 | $390.67 | $234.4K | 11,400 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | A Award deriv | 2016-01-04 | 2016-01-06 | 9,212 | — | $0 | 9,212 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | M Exercise deriv | 2015-09-17 | 2015-09-18 | 5,000 | — | $0 | 5,000 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | M Exercise | 2015-09-17 | 2015-09-18 | 5,000 | $18.61 | $93.0K | 14,000 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | S Sale | 2015-09-17 | 2015-09-18 | 5,000 | $550.00 | $2.75M | 9,000 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | M Exercise deriv | 2015-03-25 | 2015-03-26 | 5,000 | — | $0 | 10,000 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | S Sale | 2015-03-25 | 2015-03-26 | 265 | $453.71 | $120.2K | 13,435 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | S Sale | 2015-03-25 | 2015-03-26 | 200 | $457.21 | $91.4K | 9,000 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | M Exercise | 2015-03-25 | 2015-03-26 | 5,000 | $18.61 | $93.0K | 14,000 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | S Sale | 2015-03-25 | 2015-03-26 | 1,999 | $454.38 | $908.3K | 11,436 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | S Sale | 2015-03-25 | 2015-03-26 | 1,536 | $455.48 | $699.6K | 9,900 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | S Sale | 2015-03-25 | 2015-03-26 | 700 | $456.36 | $319.5K | 9,200 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | S Sale | 2015-03-25 | 2015-03-26 | 300 | $452.45 | $135.7K | 13,700 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | A Award deriv | 2015-01-02 | 2015-01-05 | 10,838 | — | $0 | 10,838 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | M Exercise deriv | 2014-03-24 | 2014-03-25 | 15,000 | — | $0 | 0 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | S Sale | 2014-03-24 | 2014-03-25 | 300 | $303.64 | $91.1K | 12,700 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | S Sale | 2014-03-24 | 2014-03-25 | 100 | $302.90 | $30.3K | 13,000 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | S Sale | 2014-03-24 | 2014-03-25 | 700 | $301.12 | $210.8K | 13,100 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | S Sale | 2014-03-24 | 2014-03-25 | 10,200 | $300.09 | $3.06M | 13,800 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | M Exercise | 2014-03-24 | 2014-03-25 | 15,000 | $23.84 | $357.6K | 24,000 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | S Sale | 2014-03-24 | 2014-03-25 | 300 | $307.65 | $92.3K | 11,900 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | S Sale | 2014-03-24 | 2014-03-25 | 100 | $313.40 | $31.3K | 9,000 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | S Sale | 2014-03-24 | 2014-03-25 | 600 | $312.29 | $187.4K | 9,100 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | S Sale | 2014-03-24 | 2014-03-25 | 1,200 | $311.46 | $373.8K | 9,700 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | S Sale | 2014-03-24 | 2014-03-25 | 600 | $310.80 | $186.5K | 10,900 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | S Sale | 2014-03-24 | 2014-03-25 | 400 | $308.25 | $123.3K | 11,500 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | S Sale | 2014-03-24 | 2014-03-25 | 300 | $304.42 | $91.3K | 12,400 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | S Sale | 2014-03-24 | 2014-03-25 | 200 | $305.25 | $61.0K | 12,200 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | A Award deriv | 2014-01-02 | 2014-01-06 | 12,750 | — | $0 | 12,750 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | G Gift | 2013-11-26 | 2014-01-06 | 590 | — | $0 | 0 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | M Exercise deriv | 2013-09-30 | 2013-10-02 | 15,000 | — | $0 | 0 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | S Sale | 2013-09-30 | 2013-10-02 | 3,887 | $312.53 | $1.21M | 19,313 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | M Exercise | 2013-09-30 | 2013-10-02 | 15,000 | $19.69 | $295.4K | 24,000 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | S Sale | 2013-09-30 | 2013-10-02 | 300 | $302.46 | $90.7K | 23,700 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | S Sale | 2013-09-30 | 2013-10-02 | 100 | $308.91 | $30.9K | 23,600 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | S Sale | 2013-09-30 | 2013-10-02 | 100 | $309.73 | $31.0K | 23,500 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | S Sale | 2013-09-30 | 2013-10-02 | 300 | $311.59 | $93.5K | 23,200 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | S Sale | 2013-09-30 | 2013-10-02 | 700 | $318.27 | $222.8K | 9,400 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | S Sale | 2013-09-30 | 2013-10-02 | 3,705 | $313.47 | $1.16M | 15,608 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | S Sale | 2013-09-30 | 2013-10-02 | 2,608 | $314.31 | $819.7K | 13,000 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | S Sale | 2013-09-30 | 2013-10-02 | 800 | $315.51 | $252.4K | 12,200 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | S Sale | 2013-09-30 | 2013-10-02 | 1,200 | $316.54 | $379.8K | 11,000 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | S Sale | 2013-09-30 | 2013-10-02 | 900 | $317.48 | $285.7K | 10,100 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | S Sale | 2013-09-30 | 2013-10-02 | 400 | $319.13 | $127.7K | 9,000 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | M Exercise deriv | 2013-06-10 | 2013-06-12 | 15,000 | — | $0 | 0 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | S Sale | 2013-06-10 | 2013-06-12 | 4,150 | $250.06 | $1.04M | 19,850 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | S Sale | 2013-06-10 | 2013-06-12 | 200 | $255.16 | $51.0K | 9,300 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | S Sale | 2013-06-10 | 2013-06-12 | 300 | $257.99 | $77.4K | 9,000 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | M Exercise | 2013-06-10 | 2013-06-12 | 15,000 | $15.80 | $237.0K | 24,000 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | S Sale | 2013-06-10 | 2013-06-12 | 756 | $254.10 | $192.1K | 9,500 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | S Sale | 2013-06-10 | 2013-06-12 | 908 | $253.50 | $230.2K | 10,256 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | S Sale | 2013-06-10 | 2013-06-12 | 4,748 | $252.32 | $1.20M | 11,164 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | S Sale | 2013-06-10 | 2013-06-12 | 3,938 | $251.67 | $991.1K | 15,912 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | A Award deriv | 2013-01-02 | 2013-01-03 | 15,000 | — | $0 | 15,000 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | M Exercise deriv | 2012-11-26 | 2012-11-27 | 1,200 | — | $0 | 1,100 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | M Exercise deriv | 2012-11-26 | 2012-11-27 | 1,100 | — | $0 | 0 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | M Exercise deriv | 2012-11-26 | 2012-11-27 | 1,100 | — | $0 | 13,900 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | M Exercise deriv | 2012-11-26 | 2012-11-27 | 6,565 | — | $0 | 7,335 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | M Exercise deriv | 2012-11-26 | 2012-11-27 | 5,035 | — | $0 | 2,300 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | M Exercise | 2012-11-26 | 2012-11-27 | 1,200 | $9.17 | $11.0K | 10,790 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | S Sale | 2012-11-26 | 2012-11-27 | 5,035 | $173.63 | $874.2K | 9,590 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | M Exercise | 2012-11-26 | 2012-11-27 | 5,035 | $9.17 | $46.2K | 14,625 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | S Sale | 2012-11-26 | 2012-11-27 | 1,200 | $172.65 | $207.2K | 9,590 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | S Sale | 2012-11-26 | 2012-11-27 | 6,565 | $174.46 | $1.15M | 9,590 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | M Exercise | 2012-11-26 | 2012-11-27 | 6,565 | $9.17 | $60.2K | 16,155 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | S Sale | 2012-11-26 | 2012-11-27 | 1,100 | $175.14 | $192.7K | 9,590 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | M Exercise | 2012-11-26 | 2012-11-27 | 1,100 | $9.17 | $10.1K | 10,690 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | S Sale | 2012-11-26 | 2012-11-27 | 1,100 | $171.45 | $188.6K | 9,590 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | M Exercise | 2012-11-26 | 2012-11-27 | 1,100 | $9.17 | $10.1K | 10,690 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | M Exercise deriv | 2012-09-06 | 2012-09-06 | 13,714 | — | $0 | 0 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | M Exercise | 2012-09-06 | 2012-09-06 | 13,714 | $15.01 | $205.8K | 23,304 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | S Sale | 2012-09-06 | 2012-09-06 | 13,714 | $150.00 | $2.06M | 9,590 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | M Exercise deriv | 2012-09-05 | 2012-09-06 | 1,286 | — | $0 | 13,714 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | M Exercise | 2012-09-05 | 2012-09-06 | 1,286 | $15.01 | $19.3K | 10,876 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | S Sale | 2012-09-05 | 2012-09-06 | 1,286 | $150.00 | $192.9K | 9,590 | SEC↗ |
| PGNX PROGENICS PHARMACEUTICALS | A Award deriv | 2012-06-13 | 2012-06-14 | 10,000 | $7.93 | $79.3K | 10,000 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | M Exercise deriv | 2012-04-19 | 2012-04-19 | 12,910 | — | $0 | 0 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | S Sale | 2012-04-19 | 2012-04-19 | 12,910 | $125.00 | $1.61M | 9,590 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | M Exercise | 2012-04-19 | 2012-04-19 | 12,910 | $18.80 | $242.7K | 22,500 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | M Exercise deriv | 2012-04-17 | 2012-04-19 | 2,090 | — | $0 | 12,910 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | M Exercise | 2012-04-17 | 2012-04-19 | 2,090 | $18.80 | $39.3K | 11,680 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | S Sale | 2012-04-17 | 2012-04-19 | 2,090 | $125.00 | $261.3K | 9,590 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | A Award deriv | 2012-01-03 | 2012-01-04 | 15,000 | — | $0 | 15,000 | SEC↗ |